Scholarlink

<p>Lacto‑N‑tetraose (LNT) is an important neutral non-fucosylated form of human milk oligosaccharides, widely recognized for its protective effects on infant health and enhancement of immune functions. In this study, to reinforce the fermentative synthesis of LNT, lactose utilization was enhanced for LNT production through overexpressing <i>lacY</i> (encoding the lactose permease gene) in <i>Escherichia coli</i> BL21, which can achieve the LNT titer and productivity of 1.55&#xa0;g/L and 0.02&#xa0;g/L/h, respectively. Moreover, the chassis was optimized through deleting byproduct genes: <i>wecB</i> (encoding UDP-N-acetyl glucosamine-2-epimerase), <i>lacZ</i> (encoding β-galactosidase), and the <i>nagB</i> gene (encoding glucosamine-6-phosphate deaminase), so we can obtain a 2.8&#xa0;g/L LNT titer and 0.039&#xa0;g/L/h productivity. Furthermore, we designed the UTP regeneration for precursor production through overexpressing the <i>ndk</i> gene (encoding nucleoside diphosphate kinase) and increased the LNT titer by 3.02&#xa0;g/L. Finally, the LNT titer and productivity were improved to 3.22&#xa0;g/L and 0.05&#xa0;g/L/h by integrating the LgtA-WbgO expression cassette in the genome. This study establishes a stepwise optimization strategy in <i>Escherichia coli</i> BL21 for LNT biosynthesis, providing a foundation for industrial-scale production.</p>

错误：搜索内容不能为空，请输入英文关键词
错误：关键词超出字数限制，请精简
高级检索

Pathway Reinforcement and Chassis Optimization of Escherichia coli BL21 for Enhancing Lacto‑N‑tetraose Production

  • 期刊论文

  • 发表日期：

    2025年10月9日

查看全文
  • Xinyue Su,
  • Yongzhong Wang,
  • Qiang Ding

摘要

Lacto‑N‑tetraose (LNT) is an important neutral non-fucosylated form of human milk oligosaccharides, widely recognized for its protective effects on infant health and enhancement of immune functions. In this study, to reinforce the fermentative synthesis of LNT, lactose utilization was enhanced for LNT production through overexpressing lacY (encoding the lactose permease gene) in Escherichia coli BL21, which can achieve the LNT titer and productivity of 1.55 g/L and 0.02 g/L/h, respectively. Moreover, the chassis was optimized through deleting byproduct genes: wecB (encoding UDP-N-acetyl glucosamine-2-epimerase), lacZ (encoding β-galactosidase), and the nagB gene (encoding glucosamine-6-phosphate deaminase), so we can obtain a 2.8 g/L LNT titer and 0.039 g/L/h productivity. Furthermore, we designed the UTP regeneration for precursor production through overexpressing the ndk gene (encoding nucleoside diphosphate kinase) and increased the LNT titer by 3.02 g/L. Finally, the LNT titer and productivity were improved to 3.22 g/L and 0.05 g/L/h by integrating the LgtA-WbgO expression cassette in the genome. This study establishes a stepwise optimization strategy in Escherichia coli BL21 for LNT biosynthesis, providing a foundation for industrial-scale production.